COPD Drug Tudorza Pressair Wins FDA Approval – Medical News Today

The FDA announced last week that it had approved the aclidinium bromide inhalation powder, for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Leave a Reply

Your email address will not be published. Required fields are marked *

*